{"id":"NCT00121108","sponsor":"MedImmune LLC","briefTitle":"MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States","officialTitle":"A Phase 3 Study of MEDI-524 (Motavizumab), an Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prevention of RSV Disease Among Native American Infants in the Southwestern United States","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-11-15","primaryCompletion":"2010-12-27","completion":"2010-12-27","firstPosted":"2005-07-21","resultsPosted":"2022-01-05","lastUpdate":"2022-01-05"},"enrollment":2127,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Healthy"],"interventions":[{"type":"BIOLOGICAL","name":"Motavizumab","otherNames":["MEDI-524"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Motavizumab","type":"ACTIVE_COMPARATOR"}],"summary":"MI-CP117 was a Phase 3, randomized, double-blind, placebo-controlled trial designed to determine if motavizumab is more effective than placebo in reducing RSV hospitalization in otherwise healthy Native American Infants in the Southwestern United States during their first RSV season.","primaryOutcome":{"measure":"Number of Participants With Respiratory Syncytial Virus (RSV) Hospitalization","timeFrame":"From study Day 0 through study Day 150","effectByArm":[{"arm":"Placebo","deltaMin":80,"sd":null},{"arm":"Motavizumab","deltaMin":21,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"0 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":20},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":["26511956"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":148,"n":708},"commonTop":["Upper respiratory tract infection","Otitis media","Pyrexia","Dermatitis diaper","Conjunctivitis"]}}